MedicationUse2-v1.0.1(2017EN): verschil tussen versies
(Copy of) |
Geen bewerkingssamenvatting |
||
Regel 1: | Regel 1: | ||
==General information== | <!-- Hieronder wordt een transclude page aangeroepen --> | ||
Name: '''nl.zorg.MedicationUse2''' [[Bestand:NL.png|link=MedicatieGebruik2-v1.0.1(2017NL)]]<BR> | {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v1.0.1(2017EN)}} | ||
Version: '''1.0.1''' <br> | <!-- Tot hier de transclude page --> | ||
HCIM Status:Final<br> | ==General information<!--hdGeneralInformation-->== | ||
Release: '''2017''' <br> | Name<!--hdName-->: '''nl.zorg.MedicationUse2''' [[Bestand:NL.png|link=MedicatieGebruik2-v1.0.1(2017NL)]]<BR> | ||
Release status: Published<br> | Version<!--hdVersion-->: '''1.0.1''' <br> | ||
Release date: 31-12-2017 | HCIM Status<!--hdStatus-->:Final<br> | ||
Release<!--hdPublication-->: '''2017''' <br> | |||
Release status<!--hdPublicationStatus-->: Published<br> | |||
Release date<!--hdPublicationDate-->: 31-12-2017 | |||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> | ||
==Metadata== | ==Metadata== | ||
Regel 61: | Regel 64: | ||
==Revision History== | ==Revision History== | ||
<div class="mw-collapsible mw-collapsed"> | <div class="mw-collapsible mw-collapsed"> | ||
''Only available in Dutch'' | ''Only available in Dutch<!--noTranslation-->'' | ||
<u>Publicatieversie 1.0</u> (04-09-2017) | <u>Publicatieversie 1.0</u> (04-09-2017) | ||
Regel 85: | Regel 88: | ||
<BR> | <BR> | ||
<imagemap> Bestand:MedicationUse2-v1.0.1Model(EN).png | center | <imagemap> Bestand:MedicationUse2-v1.0.1Model(EN).png | center | ||
rect | rect 189 99 301 163 [[HealthProfessional-v3.2(2017EN)]] | ||
rect | rect 491 488 725 548 [[#ReasonForChangeOrDiscontinuationOfUseCodList]] | ||
rect | rect 755 488 955 548 [[#MedicationUseStopTypeCodeList]] | ||
rect | rect 755 381 897 451 [[#13447]] | ||
rect | rect 639 99 751 169 [[#13449]] | ||
rect | rect 489 99 601 163 [[InstructionsForUse-v1.1(2017EN)]] | ||
rect | rect 785 244 896 308 [[#13450]] | ||
rect | rect 339 99 451 163 [[PharmaceuticalProduct-v2.0(2017EN)]] | ||
rect | rect 784 101 896 171 [[#13455]] | ||
rect | rect 180 237 322 307 [[#13448]] | ||
rect | rect 523 382 693 452 [[#13445]] | ||
rect | rect 343 382 485 452 [[TimeInterval-v1.0(2017EN)]] | ||
rect | rect 176 381 318 451 [[#13451]] | ||
rect | rect 498 237 609 307 [[#13453]] | ||
desc none | desc none | ||
</imagemap> | </imagemap> | ||
Regel 104: | Regel 107: | ||
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | {| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | ||
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; " | |-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; " | ||
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference | |style="width:30px;"|Type<!--imType-->||style="width:100px;"|Id<!--imId-->||colspan="6 " style="width:140px;"|Concept<!--imConcept-->||Card.<!--imCard-->||style="width: 600px;"|Definition<!--imDefinition-->||style="width:200px;"|DefinitionCode<!--imDefinitionCode-->||style="width:200px;"|Reference<!--imReference--> | ||
|-style="vertical-align:top; background-color: #E3E3E3; " | |-style="vertical-align:top; background-color: #E3E3E3; " | ||
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]] | |style = "text-align:center" |[[Bestand: block.png| 20px | link=]] | ||
Regel 242: | Regel 245: | ||
{| | {| | ||
|- | |- | ||
|<span | |<span title = "Codesystem: LOINC>[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment</span> | ||
|} | |} | ||
| | | | ||
|} | |} | ||
Columns Concept and DefinitionCode: hover over the values for more information<BR> | Columns Concept and DefinitionCode: hover over the values for more information<!--imHover--><BR> | ||
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]] | For explanation of the symbols, please see the legend page<!--imLegend--> [[Bestand:list2.png|link=Legend<!--wikiLegend-->]] | ||
==Example Instances== | ==Example Instances== | ||
''Only available in Dutch'' | ''Only available in Dutch<!--noTranslation-->'' | ||
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;" | {|class="wikitable" width="1316px" style= "font-size: 9.5pt;" | ||
Regel 363: | Regel 366: | ||
{| class="wikitable" width="60%" | {| class="wikitable" width="60%" | ||
|-style='vertical-align:top; background-color: #E8D7BE;' | |-style='vertical-align:top; background-color: #E8D7BE;' | ||
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1 | |Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1 | ||
|Binding<!--vsBindingTag-->: | |||
|} | |} | ||
{| class="wikitable" width="60% " | {| class="wikitable" width="60% " | ||
|-style="background-color: #1F497D; color: white; font-weight: bold; " | |-style="background-color: #1F497D; color: white; font-weight: bold; " | ||
|Conceptname | |Conceptname<!--vsConceptName--> | ||
|Conceptcode | |Conceptcode<!--vsConceptCode--> | ||
|Codesystem name||Codesystem OID | |Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID--> | ||
|Description | |Description<!--vsDescription--> | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Tijdelijk | |Tijdelijk | ||
Regel 384: | Regel 388: | ||
|Het staken van een bestaande medicamenteuze behandeling. | |Het staken van een bestaande medicamenteuze behandeling. | ||
|} | |} | ||
=== ReasonForChangeOrDiscontinuationOfUseCodList=== | === ReasonForChangeOrDiscontinuationOfUseCodList=== | ||
{| class="wikitable" width="60%" | {| class="wikitable" width="60%" | ||
|-style='vertical-align:top; background-color: #E8D7BE;' | |-style='vertical-align:top; background-color: #E8D7BE;' | ||
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2 | |Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2 | ||
|Binding<!--vsBindingTag-->: | |||
|} | |} | ||
{| class="wikitable" width="60% " | {| class="wikitable" width="60% " | ||
|-style="background-color: #1F497D; color: white; font-weight: bold; " | |-style="background-color: #1F497D; color: white; font-weight: bold; " | ||
|Conceptname | |Conceptname<!--vsConceptName--> | ||
|Conceptcode | |Conceptcode<!--vsConceptCode--> | ||
|Codesystem name||Codesystem OID | |Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID--> | ||
|Description | |Description<!--vsDescription--> | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Medication commenced (finding) | |Medication commenced (finding) | ||
|266709005 | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=266709005 266709005] | ||
|SNOMED CT | |SNOMED CT | ||
|2.16.840.1.113883.6.96 | |2.16.840.1.113883.6.96 | ||
Regel 404: | Regel 408: | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Administration of drug or medicament contraindicated (situation) | |Administration of drug or medicament contraindicated (situation) | ||
|438833006 | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=438833006 438833006] | ||
|SNOMED CT | |SNOMED CT | ||
|2.16.840.1.113883.6.96 | |2.16.840.1.113883.6.96 | ||
Regel 410: | Regel 414: | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Drug interaction (disorder) | |Drug interaction (disorder) | ||
|79899007 | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=79899007 79899007] | ||
|SNOMED CT | |SNOMED CT | ||
|2.16.840.1.113883.6.96 | |2.16.840.1.113883.6.96 | ||
Regel 416: | Regel 420: | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Hypersensitivity condition (disorder) | |Hypersensitivity condition (disorder) | ||
|473010000 | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=473010000 473010000] | ||
|SNOMED CT | |SNOMED CT | ||
|2.16.840.1.113883.6.96 | |2.16.840.1.113883.6.96 | ||
Regel 458: | Regel 462: | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|Admission to establishment (procedure) | |Admission to establishment (procedure) | ||
|305335007 | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=305335007 305335007] | ||
|SNOMED CT | |SNOMED CT | ||
|2.16.840.1.113883.6.96 | |2.16.840.1.113883.6.96 | ||
Regel 494: | Regel 498: | ||
|} | |} | ||
==This information model in other releases<!--ftOtherReleases-->== | |||
==This information model in other releases== | <!-- Hieronder wordt een transclude page aangeroepen --> | ||
--- | {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|2|2017}} | ||
== | <!-- Tot hier de transclude page --> | ||
==Information model references<!--ftReferences-->== | |||
====This information model refers to<!--ftRefersTo-->==== | |||
*[[HealthProfessional-v3.2(2017EN)|HealthProfessional-v3.2]] | |||
*[[InstructionsForUse-v1.1(2017EN)|InstructionsForUse-v1.1]] | |||
*[[PharmaceuticalProduct-v2.0(2017EN)|PharmaceuticalProduct-v2.0]] | |||
*[[TimeInterval-v1.0(2017EN)|TimeInterval-v1.0]] | |||
====This information model is used in<!--ftReferredBy-->==== | |||
:-- | |||
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->== | |||
To exchange information based on health and care information models, additional, more technical specifications are required.<BR> | To exchange information based on health and care information models, additional, more technical specifications are required.<BR> | ||
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications: | Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro--> | ||
<ul> | <ul> | ||
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.11&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li> | <li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.11&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li> | ||
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR | <li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2017}}</li> | ||
</ul> | </ul> | ||
This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]] | ==Downloads<!--ftDownloadTitle-->== | ||
==About this information== | This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]<!--ftDownloads--> | ||
The information in this wikipage is based on Release 2017 <BR> | ==About this information<!--ftHeader2-->== | ||
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR> | The information in this wikipage is based on<!--ftInfoBase--> Release 2017 <BR> | ||
This page is generated on | Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR> | ||
This page is generated on 19/12/2018 18:32:38 with ZibExtraction v. 3.0.6927.32850<!--ftDate--> <BR> | |||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> |
Versie van 20 dec 2018 13:31
General information
Name: nl.zorg.MedicationUse2
Version: 1.0.1
HCIM Status:Final
Release: 2017
Release status: Published
Release date: 31-12-2017
Metadata
DCM::CoderList | Projectgroep Medicatieproces |
DCM::ContactInformation.Address | |
DCM::ContactInformation.Name | * |
DCM::ContactInformation.Telecom | |
DCM::ContentAuthorList | Projectgroep Medicatieproces |
DCM::CreationDate | 1-2-2017 |
DCM::DeprecatedDate | |
DCM::DescriptionLanguage | nl |
DCM::EndorsingAuthority.Address | |
DCM::EndorsingAuthority.Name | PM |
DCM::EndorsingAuthority.Telecom | |
DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.9.11 |
DCM::KeywordList | Medicatie, Gebruik |
DCM::LifecycleStatus | Final |
DCM::ModelerList | Architectuurgroep Registratie aan de Bron |
DCM::Name | nl.zorg.MedicatieGebruik2 |
DCM::PublicationDate | 31-12-2017 |
DCM::PublicationStatus | Published |
DCM::ReviewerList | Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron |
DCM::RevisionDate | 31-12-2017 |
DCM::Superseeds | nl.zorg.MedicatieGebruik2-v1.0 |
DCM::Version | 1.0.1 |
HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (04-09-2017)
Publicatieversie 1.0.1 (31-12-2017)
ZIB-618 | Hernoemen Verstrekking naar Medicatieverstrekking |
ZIB-643 | Kleine tekstuele verbeteringen |
Concept
MedicationUse is a statement on the historic, current or intended use of a certain medicine.
Purpose
The goal of the medication use is to provide insight into the patient’s pattern of use.
Information Model
Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | |||||||
NL-CM:9.11.21338 | MedicationUse | Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model. | |||||||||||
NL-CM:9.11.23290 | Prescriber::HealthProfessional | 0..1 | The health professional that entered the medication agreement with the patient. |
| |||||||||
NL-CM:9.11.21339 | ProductUsed::FarmaceuticalProduct | 1 | The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.
In principle, this will be the prescribed product, but the product used may differ from the prescribed product. |
| |||||||||
NL-CM:9.11.22504 | InstructionsForUse | 0..1 | Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed. |
| |||||||||
NL-CM:9.11.22398 | MedicationUseDateTime | 1 | Date on which this use is entered. | ||||||||||
NL-CM:9.11.22663 | PeriodOfUse | 0..1 | Medication use can be recorded for a certain moment or over a certain period. Thus, medication use can be recorded multiple times during the use of medication. The usage period is the period or moment over which the data is recorded.
Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days. End date: The time at which the period of use ends (or ended or will end). To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date. |
| |||||||||
NL-CM:9.11.22492 | AsAgreedIndicator | 0..1 | Is the medicine used as outlined in the medication agreement? | ||||||||||
NL-CM:9.11.22399 | UseIndicator | 1 | Is this medicine used or not? | ||||||||||
NL-CM:9.11.22491 | ReasonForUse | 0..1 | The reason for using the medication, particularly in self-care medicine purchased by the patient themselves. | ||||||||||
NL-CM:9.11.23132 | MedicationUseStopType | 0..1 | Stop type, the manner in which this medication is discontinued (temporary or definitive). |
| |||||||||
NL-CM:9.11.22493 | ReasonForChangeOrDiscontinuationOfUse | 0..* | Reason for changing or discontinuing use of medication. |
| |||||||||
NL-CM:9.11.21624 | Comment | 0..1 | Comments on the medication use. |
|
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page
Example Instances
Only available in Dutch
MedicatieGebruik DatumTijd | GebruikIndicator | VolgensAfspraak Indicator | Medicatiegebruik Stoptype | Gebruiksperiode | Gebruiksproduct | ||
Ingangsdatum | Einddatum | Gebruiksduur | ProductCode | ||||
3-6-2014 16:19:07 | Ja | Mei 2014 | 1 maand | Paracetamol tablet 500 mg | |||
11-9-2012 17:21:00 | Ja | Ja | 01-09-12 | 05-09-12 | Pantoprazol injpdr 40 mg fl | ||
19-9-2014 4:12:11 | Nee | Nee | Definitief | 17-09-14 | Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml |
RedenGebruik | RedenWijzigen OfStoppen Gebruik | GebruiksInstructie | |||||
Omschrijving | ToedieningsWeg | Aanvullende instructie | Doseerinstructie | ||||
Doseerduur | Dosering| Keerdosis | Toedieningsschema |Frequentie |Interval |Toedientijd |Weekdag |Dagdeel | |||||
Pijn | In de maand mei heb ik regelmatig paracetamol gebruikt. | ||||||
Ulcusprofylaxe | Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st) | iv | 40 mg (=1 st) | 1x per dag om 8.00 uur | |||
(Mogelijke) bijwerking | Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid. | subcutaan | 2500 IE | 1x per dag om 18.00 uur |
Valuesets
MedicationUseStopTypeCodeList
Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1 | Binding: |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Tijdelijk | 1 | Medicatieafspraak StopType | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 | Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). |
Definitief | 2 | Medicatie afspraak StopType | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 | Het staken van een bestaande medicamenteuze behandeling. |
ReasonForChangeOrDiscontinuationOfUseCodList
Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2 | Binding: |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Medication commenced (finding) | 266709005 | SNOMED CT | 2.16.840.1.113883.6.96 | Starten medicamenteuze behandeling |
Administration of drug or medicament contraindicated (situation) | 438833006 | SNOMED CT | 2.16.840.1.113883.6.96 | Contra-indicatie |
Drug interaction (disorder) | 79899007 | SNOMED CT | 2.16.840.1.113883.6.96 | Interactie |
Hypersensitivity condition (disorder) | 473010000 | SNOMED CT | 2.16.840.1.113883.6.96 | Overgevoeligheid |
Geen of onvoldoende effect | 5 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Geen of onvoldoende effect |
Te sterk effect | 6 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Te sterk effect |
(Mogelijke) bijwerking | 7 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | (Mogelijke) bijwerking |
Toedieningsweg voldoet niet | 8 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Toedieningsweg voldoet niet |
Indicatie vervallen | 9 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Indicatie vervallen |
Beleidswijziging | 10 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Beleidswijziging |
Admission to establishment (procedure) | 305335007 | SNOMED CT | 2.16.840.1.113883.6.96 | Opname |
Wens patiënt | 12 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Wens patiënt |
Volgens afspraak | 13 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Volgens afspraak |
Hervatten beleid vorige voorschrijver | 14 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Hervatten beleid vorige voorschrijver |
Geplande procedure | 15 | Medicatieafspraak Reden | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2 | Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc. |
Overig | OTH | NullFlavour | 2.16.840.1.113883.5.1008 | Overig |
This information model in other releases
- Prerelease 2018-2, (Version 1.0.1)
- Prerelease 2019-2, (Version 1.1)
- Release 2020, (Version 1.1.1)
- Prerelease 2021-2, (Version 1.2)
- Prerelease 2022-1, (Version 2.0)
- Prerelease 2023-1, (Version 2.1)
- Prerelease 2024-1, (Version 3.0)
Information model references
This information model refers to
This information model is used in
- --
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
Downloads
This information model is also available as pdf file or as spreadsheet
About this information
The information in this wikipage is based on Release 2017
Conditions for use are located on the mainpage
This page is generated on 19/12/2018 18:32:38 with ZibExtraction v. 3.0.6927.32850